Navigation Links
FDA Approves 3 New Drugs for Type 2 Diabetes
Date:1/28/2013

FRIDAY, Jan. 25 (HealthDay News) -- The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.

All three drugs contain a new active ingredient, alogliptin, either alone or in combination with other, previously approved medications. The newly approved drugs include Nesina (alogliptin), Kazano (alogliptin plus metformin) and Oseni (alogliptin plus pioglitazone), the FDA said in a news release.

"Controlling blood sugar levels is very important in the overall treatment and care of diabetes," Dr. Mary Parks, director of the Division of Metabolism and Endocrinology Products in the FDA's Center for Drug Evaluation and Research, said in the statement. "Alogliptin helps stimulate the release of insulin after a meal, which leads to better blood sugar control."

More than 24 million people in the United States are currently affected by type 2 diabetes, which is closely linked with obesity. In the type 2 form of the disease, people gradually develop resistance to insulin or fail to produce enough of the hormone, resulting in rising blood sugar levels. That can lead to other health problems, such as heart disease, vision problems and neural or kidney dysfunction.

The FDA urges that the new medications be used in combination with a healthy diet and exercise to help bring diabetes under control. All of the drugs underwent study either as stand-alone products or used alongside standard diabetes medications such as sulfonyureas or insulin.

In the case of Nesina, the drug showed safety and effectiveness across 14 clinical trials, involving more than 8,500 patients, according to the FDA. The most common side effects included stuffy or runny nose, headache, and upper respiratory tract infections.

Kazano's safety and effectiveness were tested in four clinical trials involving more than 2,500 patients. Side effects included those seen with Nesina, as well a
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. FDA Approves 1st Skin Patch to Combat Migraines
2. Environmental Protection Agency Approves MOMS by OdorXit as a Disinfectant
3. FDA Approves New Type of Flu Vaccine
4. FDA Approves New Once-a-Day HIV Pill
5. FDA Approves Flu Vaccine for Coming Season
6. FDA Approves 2nd New Weight-Loss Drug
7. FDA Approves 1st Pill to Help Prevent HIV Infection
8. FDA Approves First New Weight-Loss Drug in More Than a Decade
9. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
10. FDA Approves Combo Shot for Meningitis, Hib in Kids
11. FDA Approves Generic Versions of Plavix
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves 3 New Drugs for Type 2 Diabetes
(Date:5/22/2013)... Yoga of Lady Niguma was created by a female yogi (‘yogini’) ... the oldest yoga found in written form (in a book made ... renowned Indian master and yogi Naropa, and the yoga she created ... master. , Lady Niguma taught the practice to her student ... lineage to the second Dalai Lama, Gendun Gyatso. While researching rare ...
(Date:5/22/2013)... A new study published online today (Thursday) in the ... who visited fast food or chain restaurants in the U.S. ... likely to use calorie information given in the restaurants to ... eating at fast food or chain restaurants twice a week ... as those eating there once a week or less. , ...
(Date:5/22/2013)... Hosted by the California Dental Association Foundation and ... than $1.6 million in charitable dental services during the ... , The California Dental Association Foundation and the California ... services and oral health education to Californians who experience ... by CDA and CDAF in the past 12 months. ...
(Date:5/22/2013)... Zensah® Compression Apparel released a statement ... titled "Breast pain while running affects one-third of ... help." According to the article, a British study surveyed ... suffer from breast pain while running but do not ... , Zensah emphasizes the importance for women to ...
(Date:5/22/2013)... Reporter , , WEDNESDAY, May 22 (HealthDay News) -- People ... likely to attempt suicide, whether or not they also ... a new study. "Clinicians who are seeing patients ... at increased risk of suicide," said study co-author Mark ... Resource and Evaluation Center in Ann Arbor, Mich. ...
Breaking Medicine News(10 mins):Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 2Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 3Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3
... new study from Harvard School of Public Health (HSPH) and ... between the common sexually transmitted infection, Trichomonas vaginalis ... in men. The study appears online on September 9, ... website and will appear in a later print edition. ...
... H1N1 influenza vaccine in pregnant women is launching this ... (NIAID), part of the National Institutes of Health, announced ... severe illness if they become infected with influenza virus ... to receive the seasonal influenza vaccine every year," says ...
... , , CAMARILLO, Calif., Sept. ... National Science Foundation (NSF) recently honored Dr. Blake Gillespie, Assistant ... Development (CAREER) award. , , The ... and research in protein-ligand interactions and biomolecular dynamics, is supported ...
... extend to staph infections, researchers say , WEDNESDAY, Sept. ... anti-microbial properties, might kill MRSA bacteria. , A new ... the honey, made solely from flowers found on the ... FabI protein, which is needed for fatty acid biosynthesis. ...
... to awaken dormant, common virus that crosses over into brain ... discovered part of the reason why Tysabri, a drug used ... a rare but potentially deadly brain disease in some patients. ... virus from its slumber, allowing it to cross into the ...
... , WASHINGTON, Sept. 9 Statement of ... Legal Reform, on reports from White House press secretary Robert ... tonight,s speech to Congress: , , (Logo: ... "We are encouraged that President Obama understands the tremendous ...
Cached Medicine News:Health News:Link found between common sexual infection and risk of aggressive prostate cancer 2Health News:NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women 2Health News:CI Faculty Member Awarded Nearly $1 Million NSF Grant 2Health News:MRSA May Succumb to Honey 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:U.S. Chamber Encourages Obama to Propose Meaningful Medical Liability Reforms in Speech to Congress 2
(Date:5/22/2013)... Advanced Prenatal Therapeutics (APT), a privately held ... alleviate the high blood pressure and other symptoms associated ... be the first medical device specifically designed to treat ... Every year, preeclampsia affects approximately 300,000 pregnant ... It is characterized by high blood pressure and proteinuria ...
(Date:5/22/2013)... , May 22, 2013   Accuray Incorporated ... its management is scheduled to present at the 2013 ... on Thursday, June 6, 2013 at 1:30 ... of the presentation will be available online from the ... . The webcast replay of the presentation ...
(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling.  While more than half of these ... hyperhidrosis is a serious medical condition.  Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Is There Finally A Way To Stop Severe Excessive Sweating? 2
... CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Curis, ... novel targeted,medicines primarily for cancer treatment, today ... presentations at the 98th Annual Meeting,of the ... AACR, Curis also disclosed that its April ...
... 17, 2007 /PRNewswire-FirstCall/ --,Telik, Inc. announced the ... clinical trial of the triplet combination of ... the,first-line treatment of advanced non-small cell lung ... significant,improvement in both progression-free survival and overall ...
Cached Medicine Technology:Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR 2Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR 3Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR 4Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 2Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 3Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer 4
Micro-mini fiber optic light....
Miniature high intensity fiber optic light. The ultra-thin fiber-optic cable is smaller and lighter than a standard electrical cord....
... Halogen technology provides a ... is variable by 5 different ... continuously (Halogen 250). Light output ... illumination conditions (large cavity, small ...
A three lamp light source maximizes use by allowing two surgeons to work simultaneously from it, while the third lamp is reserved for backup....
Medicine Products: